Go to deals
Healthcare

A group of individual investors has acquired Saneca/Slovakofarma Hlohovec

In this asset deal, a group of private investors has acquired Saneca's cosmetic products portfolio and its pharmaceutical manufacturing plant in Slovakia, from Sanofi. Financial terms of this transaction have not been disclosed.

Saneca (originally Zentiva Hlohovec) is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns portfolio of cosmetic and generic products.

Sanofi is a global integrated healthcare leader engaged in the research, development, manufacturing and marketing of therapeutic solutions.

Oaklins' team in Slovakia advised the buyer in this transaction. The process included due diligence, valuation, negotiation of transaction terms, and selection of new management in the newly purchased entity.

Parties

Talk to the deal team

Lubomir Soltys

Partner
Bratislava, Slovakia
Oaklins WOOD & Co.

Michal Staron

Managing Director
Bratislava, Slovakia
Oaklins WOOD & Co.

Related deals

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Healthcare | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Learn more